<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E8211E4A-01C5-4A4F-9A2D-5006173F6BA2"><gtr:id>E8211E4A-01C5-4A4F-9A2D-5006173F6BA2</gtr:id><gtr:name>Beijing Institute of Oriental Life Research and Bioon</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/80289143-5CA3-46B0-A3AA-1E1D2B1AE4AB"><gtr:id>80289143-5CA3-46B0-A3AA-1E1D2B1AE4AB</gtr:id><gtr:name>Global Stem Cell &amp; Regenerative Medicine Acceleration Centre (GSRAC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/08C52B07-D973-4565-8E88-5511BAFFF3D9"><gtr:id>08C52B07-D973-4565-8E88-5511BAFFF3D9</gtr:id><gtr:name>Peking Union Medical College</gtr:name><gtr:address><gtr:line1>Dongdan Santiao</gtr:line1><gtr:postCode>100005</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CB1BB786-BF59-4FDB-BAA1-81ABD920E4EA"><gtr:id>CB1BB786-BF59-4FDB-BAA1-81ABD920E4EA</gtr:id><gtr:name>University of Delhi</gtr:name><gtr:address><gtr:line1>North Campus</gtr:line1><gtr:postCode>110007</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/683A0DAC-85B9-4DA6-A31C-7741C2301BAF"><gtr:id>683A0DAC-85B9-4DA6-A31C-7741C2301BAF</gtr:id><gtr:name>Society for Community Health Awareness Research and Action (SOCHARA)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:department>Sch of Global Studies</gtr:department><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E8211E4A-01C5-4A4F-9A2D-5006173F6BA2"><gtr:id>E8211E4A-01C5-4A4F-9A2D-5006173F6BA2</gtr:id><gtr:name>Beijing Institute of Oriental Life Research and Bioon</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/80289143-5CA3-46B0-A3AA-1E1D2B1AE4AB"><gtr:id>80289143-5CA3-46B0-A3AA-1E1D2B1AE4AB</gtr:id><gtr:name>Global Stem Cell &amp; Regenerative Medicine Acceleration Centre (GSRAC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/08C52B07-D973-4565-8E88-5511BAFFF3D9"><gtr:id>08C52B07-D973-4565-8E88-5511BAFFF3D9</gtr:id><gtr:name>Peking Union Medical College</gtr:name><gtr:address><gtr:line1>Dongdan Santiao</gtr:line1><gtr:postCode>100005</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CB1BB786-BF59-4FDB-BAA1-81ABD920E4EA"><gtr:id>CB1BB786-BF59-4FDB-BAA1-81ABD920E4EA</gtr:id><gtr:name>University of Delhi</gtr:name><gtr:address><gtr:line1>North Campus</gtr:line1><gtr:postCode>110007</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/683A0DAC-85B9-4DA6-A31C-7741C2301BAF"><gtr:id>683A0DAC-85B9-4DA6-A31C-7741C2301BAF</gtr:id><gtr:name>Society for Community Health Awareness Research and Action (SOCHARA)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/B604FC0F-846E-41BF-A43F-09A9D4B57780"><gtr:id>B604FC0F-846E-41BF-A43F-09A9D4B57780</gtr:id><gtr:firstName>Prasanna</gtr:firstName><gtr:otherNames>Kumar</gtr:otherNames><gtr:surname>Patra</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/805752AE-47F9-405B-93C7-DE951C00C1EB"><gtr:id>805752AE-47F9-405B-93C7-DE951C00C1EB</gtr:id><gtr:firstName>Adrian Vincent</gtr:firstName><gtr:surname>Ely</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B7D76C06-118E-40B7-B843-DACB1325BEDC"><gtr:id>B7D76C06-118E-40B7-B843-DACB1325BEDC</gtr:id><gtr:firstName>Suli</gtr:firstName><gtr:surname>Sui</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D62C2A3A-6D1B-4013-A255-51932AE005DB"><gtr:id>D62C2A3A-6D1B-4013-A255-51932AE005DB</gtr:id><gtr:firstName>Margaret</gtr:firstName><gtr:otherNames>Elizabeth</gtr:otherNames><gtr:surname>Sleeboom-Faulkner</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=ES%2FI018107%2F1"><gtr:id>8D73372D-DF34-48A9-B337-00A15F26EDE4</gtr:id><gtr:title>Bionetworking in Asia - International collaboration, exchange, and responsible innovation in the life sciences</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>ES/I018107/1</gtr:grantReference><gtr:abstractText>&lt;p>The project Bionetworking in Asia aims to uncover how international life science collaborations deal with ?differences? between research institutions in countries with high- and low-incomes. It examines how public health concerns and policies, and varying healthcare systems and epidemiological analyses are reflected in the needs, preferences and behaviour of stakeholders and established international research standards. It further investigates how these differences translate into the bargaining position of researchers, patients and scientists.&lt;br />&lt;br />Building on observations of scientists, managers and patients, it analyses ways in which regional differences and inequalities play a role in the ?bionetworks? used for patient recruitment and international research agreements. Bionetworking is a social entrepreneurial activity involving biomedical research, healthcare and patient networks that are maintained by taking advantage of regionally differences in levels of science and technology, healthcare, education and regulatory regimes.&lt;br />&lt;br />The research uses methods of participant observation, interview, backward mapping, option creation, and social network analysis to examine international science collaborations in the fields of experimental stem cell therapies and biobanking in Asia. The research results aim to reveal how knowledge of informal patient-, research- and hospital networks can be translated into improved guidance for research collaboration, patient support and policy guidelines.&lt;/p></gtr:abstractText><gtr:fund><gtr:end>2015-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/924BE15C-91F2-4AAD-941A-3F338324B6AE"><gtr:id>924BE15C-91F2-4AAD-941A-3F338324B6AE</gtr:id><gtr:name>ESRC</gtr:name></gtr:funder><gtr:start>2011-12-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1114765</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Beijing Institute of Oriental Life Research and Bioon</gtr:collaboratingOrganisation><gtr:country>China, People's Republic of</gtr:country><gtr:description>Roundtable on Patient Needs in Beijing</gtr:description><gtr:id>48734C4F-1790-4838-BEC9-D20EADAD6815</gtr:id><gtr:impact>This event brought together patients, stem cell researchers, medical professionals and regulators to talk about patient needs, discussing the potential usage of stem cell therapy in the future. The ground-braking roundtable on patient needs was open to the public, and it put 'patient needs' at the centre of the discussion on stem cell therapies as one solution among many. About 60 participants attended this event. 
We disseminated the information on the Internet, with the help from Bioon.</gtr:impact><gtr:outcomeId>545cd5385b81f1.38599108-1</gtr:outcomeId><gtr:partnerContribution>The Beijing Institute of Oriental Bioculture was involved in many brainstorming preparation meetings and helped us to invite scholars, practitioners and patients. They also contributed to formulating the topics of the event. The Bioon helped us to disseminate the information, before, during and after the event. They also helped us to prepare the booklet and invite scholars in the field of stem cell research.</gtr:partnerContribution><gtr:piContribution>The interactive public event was organised by the Centre for Bionetworking and the Xiannongtan Residential Community in collaboration with the Beijing Institute of Oriental Life Research and Bioon, Bio-Events, China</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Peking Union Medical College</gtr:collaboratingOrganisation><gtr:country>China, People's Republic of</gtr:country><gtr:description>Collaboration with Peking Union Medical College, beijing</gtr:description><gtr:id>A87EB859-498A-422B-ABE4-808AD66C4E5B</gtr:id><gtr:impact>report: mini workshop, report: roundtable</gtr:impact><gtr:outcomeId>5464860febf2d5.79619114-1</gtr:outcomeId><gtr:partnerContribution>They are co-organisers in the Mini-Workshop and the Roundtable</gtr:partnerContribution><gtr:piContribution>Suli Sui and Xinqing Zhang have been conducting research into the regulation of biobanking and stem cell therapy provision in China. They are co-organisers in the Mini-Workshop and the Roundtable</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Global Stem Cell &amp; Regenerative Medicine Acceleration Centre (GSRAC)</gtr:collaboratingOrganisation><gtr:country>Korea, Republic of</gtr:country><gtr:description>collaborative relationship with the Global Stem Cell &amp;amp; Regenerative Medicine Acceleration Center</gtr:description><gtr:id>459F1492-2A85-4419-A70A-E1A7A7026839</gtr:id><gtr:impact>facilitated the public discussion on stem cell technology and tackled the gap between patients'
expectations and scientific progress</gtr:impact><gtr:outcomeId>545b4bcbb36b68.92122888-1</gtr:outcomeId><gtr:partnerContribution>helped to facilitate the public discussion on stem cell technology and tackle the gap between patients'
expectations and scientific progress on stem cell therapies by inviting both patients and
scientists/clinicians in the debate.</gtr:partnerContribution><gtr:piContribution>public debate event in
collaboration with the Global Stem Cell &amp;amp; Regenerative Medicine Acceleration Center in order to
facilitate the public discussion on stem cell technology and tackle the gap between patients'
expectations and scientific progress on stem cell therapies by inviting both patients and
scientists/clinicians in the debate.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Society for Community Health Awareness Research and Action (SOCHARA)</gtr:collaboratingOrganisation><gtr:country>India, Republic of</gtr:country><gtr:description>Collaboration with SOCHARA to organise deliberative workshop on 'Stem Cell Research and Patient Needs in India' (October 5th, 2013 in Bangalore, India)</gtr:description><gtr:id>B6F825ED-D7B6-47A4-B466-B227B4E602FA</gtr:id><gtr:impact>Deliberative workshop on 'Stem cell research and patient needs in India' held on October 5th, 2013 in Bangalore India</gtr:impact><gtr:outcomeId>545b469a78e049.48499833-1</gtr:outcomeId><gtr:partnerContribution>The collaborating partner organisation provided input on the research design and the participants to be invited as well as contributed to the organisational logistics for the event</gtr:partnerContribution><gtr:piContribution>Our research team initiated the collaboration along with the research design and structure</gtr:piContribution><gtr:sector>Learned Society</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Beijing Institute of Oriental Life Research and Bioon</gtr:collaboratingOrganisation><gtr:country>China, People's Republic of</gtr:country><gtr:description>Collaboration with Bioon, Bio-Events, China to organise the Roundtable</gtr:description><gtr:id>815D7E7D-5A2E-4F0A-812A-34FA3138D2F5</gtr:id><gtr:impact>Sand drawing, audio recording of Roundtable</gtr:impact><gtr:outcomeId>546486ef2a4513.24330815-1</gtr:outcomeId><gtr:partnerContribution>Collaboration with Bioon, Bio-Events, China to organise the Roundtable</gtr:partnerContribution><gtr:piContribution>Collaboration with Bioon, Bio-Events, China to organise the Roundtable</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Delhi</gtr:collaboratingOrganisation><gtr:country>India, Republic of</gtr:country><gtr:department>RIS, New Delhi and East Asian Studies Department</gtr:department><gtr:description>Collaborated with Research and Information System in Developing Countries (RIS), New Delhi and Department of East Asian Studies, University of Delhi to organize a roundtable discussion on 'Governance of Regenerative Medicine and Patients' Needs in India'</gtr:description><gtr:id>460DB44C-4AC5-45FC-936C-61755835591E</gtr:id><gtr:impact>Policy briefing mentioned above.</gtr:impact><gtr:outcomeId>545b47885e0bd7.88083260-1</gtr:outcomeId><gtr:partnerContribution>See above.</gtr:partnerContribution><gtr:piContribution>The Centre for Bionetworking acted as the primary organiser and, together with the partnering organisations, came up with the conceptual rationale and format for the event. All three partners worked together in selecting participants and coordinating the logistical details (venue, publicity, transport for participants, etc).</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Public debate on 'Patient needs and stem cell research' in Seoul, South Korea</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CEF530C4-04FD-4E8C-A77D-E10026A4E8CC</gtr:id><gtr:impact>There was a consensus among scientists, policy makers and patients that a proper information channel is much needed to provide patients with impartial and balanced information about various symptoms, diseases and remedies.

Professor Sora Park, Director of the Global Stem Cell &amp;amp; Regenerative Medicine Acceleration Center, proposed hosting a series of similar events on stem cell and regenerative medicine in the near future to cater for patients' needs for specific information about their own diseases.</gtr:impact><gtr:outcomeId>55c0d8e0566657.04849868</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.centreforbionetworking.org/successful-public-debate-patient-needs-stem-cell-research-seoul-2nd-june-2014/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Roundtable Discussion Beijing with stem cell researchers and doctors in the First Affiliated Hospital of Suzhou University</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3CF0633C-FF12-4555-92FB-6204D8D76628</gtr:id><gtr:impact>talk sparked questions and discussion afterwards

n/a</gtr:impact><gtr:outcomeId>54649d9bbfb466.03985958</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.centreforbionetworking.org/ground-breaking-roundtable-discusses-cater-patient-needs-china/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Asian Bioethics: 'Asia' as a platform for bioethics debate, Keynote speech, International Symposium: Comparative and Cross-cultural bioethics: Issues and methodologies, University of Otago March 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3A53277D-F6F6-4614-A6B8-9F282A1DF1D3</gtr:id><gtr:impact>Talk sparked questions and discussion afterwards

discussed regulation of stem cell research</gtr:impact><gtr:outcomeId>54649ec63e9a40.03462385</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.centreforbionetworking.org/wp-content/uploads/2014/11/UK-Japan-Stem-Cell-Workshop-Held-at-iCeMS-Building-a-Better-Environment-for-Application-Kyoto-University-iCeMS.pdf</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Conference on Catastrophic Risk, Centre for the Study of Existential Risks: Title - Gene drive technology: challenges to global risk management and governance - A. Rosemann</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4251A471-F035-4B24-A9E6-74EF576B630E</gtr:id><gtr:impact>(2016) 'Gene drive technology: challenges to global risk management and governance. Conference on Catastrophic Risk, Centre for the Study of Existential Risks, Clare College, Cambridge, December 14 2016.</gtr:impact><gtr:outcomeId>58779ac3544158.49159127</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Lecture Series (Sussex) (ongoing, various occurrences)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>D4857B4A-73F6-480A-8C8E-C4CC73D38FD8</gtr:id><gtr:impact>Each lecture attracted around 15 students and staff to attend the public lecture with discussions 


Audiences from different departments get involved in the discussion of different aspects of innovative biotechnology or therapy.</gtr:impact><gtr:outcomeId>5453a219ab9c93.66397198</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>http://www.centreforbionetworking.org/news-and-events/</gtr:url><gtr:year>2013,2014,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Film Screening 'Stem Cell Revolutions'</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>88A9E23E-B537-4639-A667-97A8463E8FAD</gtr:id><gtr:impact>Film sparked questions and discussion afterward to an expert panel

Sparked much thought and discussion</gtr:impact><gtr:outcomeId>55c0d717e62f25.04744125</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.centreforbionetworking.org/stem-cell-film/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Deliberative workshop on Stem cell research and patient needs in India' held on October 5th, 2013 (Bangalore, India)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6555E77B-94BF-4BF0-B255-D4C5678161D0</gtr:id><gtr:impact>14 stakeholders participated in the workshop where they exchanged and debated the topic of stem cell research and patient needs in India


Below are a selection from the feedback we received from participants:I definitely enjoyed the interaction we had and I know I came away with plenty to think about. Ethics, principles, mehanics aside, this is a very promising course being taken and we all know that it wont be long till the unfortunate will find an answer to their despair...I wish you well and hope to have the pleasure of meeting with all of you and hearing good news !' Thanks to all &amp;amp; Sussex university for conducting this Fantastic &amp;amp; gainful meeting . A Small hope that spinal cord injury etc. Can be cured with stem cells . This effort highly appreciated &amp;amp; coming forward looking for more.' Thanks for inviting me as a participant for the workshop. It was indeed a very good platform for a stimulating discussion. A well thought and conceptualized way of gathering feedback all stake holders to see the future of stem cells and their promise. Hope the outcomes of these workshop transform into getting a step closer to discover the true potential and promise, stem cells hold for patients at large. Hope this paves for good thing in future.'</gtr:impact><gtr:outcomeId>545b48dc142ae3.36932422</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:url>http://www.centreforbionetworking.org/india-workshop/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Roundtable on Patient Needs in Beijing</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>66DE4F8B-C021-4B90-92C2-FC505BE90444</gtr:id><gtr:impact>This event brought together patients, stem cell researchers, medical professionals and regulators to talk about patient needs

During the interactive discussion, the panel and audience exchanged ideas, evaluated the similarities and the differences of their experiences, and sparked new thoughts on how to better address patient needs in new medical technologies such as stem cell research.</gtr:impact><gtr:outcomeId>545cd0fb7c6053.62945044</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:url>http://www.centreforbionetworking.org/ground-breaking-roundtable-discusses-cater-patient-needs-china/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Short Interview in the programme &quot;Impact&quot; (BBC World News) on the scientific rise of China by  A. Rosemann</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3489171C-659D-4A7C-BD91-9B20C6EB88FD</gtr:id><gtr:impact>BBC World News (TV Channel). Short Interview in the programme &amp;quot;Impact&amp;quot; on the scientific rise of China</gtr:impact><gtr:outcomeId>58778d0eedcd89.66347486</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public event:  Regulating 'stem cell tourism' in the UK and Asia: How do we move forward together?</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>00FA54C1-37BC-419C-9F66-24A18C25F051</gtr:id><gtr:impact>Talk sparked questions and discussion that will continue far beyond the scope of the single event.

n/a</gtr:impact><gtr:outcomeId>55c1f7bcb2aa21.15956045</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.centreforbionetworking.org/news-and-events/regulating-stem-cell-tourism-in-the-uk-and-asia-how-do-we-move-forward-together/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Roundtable Discussion on 'Governance of Regenerative Medicine and Patients' Needs in India' held in New Delhi on 02 July 2014.</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4B1174A9-3286-480D-847D-95D6F77CDAF3</gtr:id><gtr:impact>Around 80 people, including expert panellists and general public participated in the event.

Below are a sample of feedbacks that we received from our participants: &amp;quot;I have been reading a lot about stem cell research and therapy throughout my course of study. Learning its governance aspect was interesting. And I am sure the knowledge I amassed from the roundtable will help me in the future&amp;quot;. &amp;quot;The idea of having different people directly connected to regenerative medicine was interesting. Scientists, doctors, patients and care takers everyone had different, contradictory yet valid take on the subject&amp;quot;. &amp;quot;I am very fortunate to have participated in the event. It should not be limited to big cities. Similar programmes should be organized in smaller cities and rural areas&amp;quot;. &amp;quot;We need more such programmes in India&amp;quot;. &amp;quot;It was a well thought out programme that could involve all possible and important stakeholders linked to the issue&amp;quot;.</gtr:impact><gtr:outcomeId>545b499028cae3.76731345</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.centreforbionetworking.org/centre-bionetworking-co-organises-expert-roundtable-patient-needs-stem-cell-research-new-delhi-india/?preview=true&amp;preview_id=1609&amp;preview_nonce=e35dbc0ced</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture Regulation of Cell Research and Therapy: International: Standardisation and National Home-Keeping, International Cell Therapy Conference, Shanghai</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9B04F160-805C-4361-AEC3-C7FB02B67856</gtr:id><gtr:impact>Talk sparked questions and discussion afterwards

n/a</gtr:impact><gtr:outcomeId>54649c5f65a864.49999896</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.centreforbionetworking.org/wp-content/uploads/2014/11/2014?6?20?21??????????mBeijing.pdf</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>'Governing human gene drive research: challenges from a global perspective', 41st 4S Annual Meeting Barcelona, Spain, September 2, 2016. - A.Rosemann</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CD080B95-36C1-4C83-9794-9BE3C85BFEAA</gtr:id><gtr:impact>(2016) 'Governing human gene drive research: challenges from a global perspective', 41st 4S Annual Meeting Barcelona, Spain, September 2, 2016.</gtr:impact><gtr:outcomeId>58779c21eb81b3.00045400</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Conference: Global Life Science and Bionetworking -- Cell Therapy Production, Provision and Policies</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>146170E1-F55F-4759-BB86-E3E9001C25CB</gtr:id><gtr:impact>Various panels including a high-profile expert policy panel sparked questions and much discussion

Scholars have collaborated on academic paper series and special issues relating to the the panels and discussions</gtr:impact><gtr:outcomeId>55c1d4a40cf4a9.99667436</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.centreforbionetworking.org/global-life-science-bionetworking-cell-therapy-production-provision-policies/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Patient Organisation Activism Around the World</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>80D4227E-9D3F-41B1-9051-114D110453A0</gtr:id><gtr:impact>talk sparked questions and discussion afterwards

The various patient organisations we've worked with have been put in contact with each other to further exchange ideas and information on how they operate and what works with them in their respective countries</gtr:impact><gtr:outcomeId>55c0decf6ff255.48333959</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:url>http://www.centreforbionetworking.org/patient-organisation-activism-around-the-world/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Presentation:  Hung-Chieh Chang (China)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F592C94D-FE6F-4840-8D3A-AEEB46FEC1E0</gtr:id><gtr:impact>12 scientists attended the presentation and discussion afterwards. 


Gained trust from the researched audiences, and get access to the biotechnology park. Stimulate communication between science and social science.</gtr:impact><gtr:outcomeId>5453a2c9c10416.11041282</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>1. Policy and public - patients and stem cell science
Our research regarding patients with muscular dystrophy, spinal cord injury, cardiovascular disease and diabetes mellitus shows that high-tech approaches are crucial only to some patients in particular cultural and socio-economic environments (Sleeboom-Faulkner et al 2016; Heitmeyer et al 2016; Kato - under review). This insight resulted from research using the interview methodology of Criteria Option Generation (COG), enabling interviewees to reflect upon and develop their own views on patient needs and stem cell science, attached to deliberative workshops (COG-DW) - patients from different disease backgrounds, ethicists, medical professionals and scientists debated funding distribution, regulation and therapy provision in deliberative workshops (http://www.sussex.ac.uk/internal/bulletin/staff/2013-14/111013/stemcellresearch). Insights from these workshops were carried on to a higher profile roundtable debate (http://www.sussex.ac.uk/staff/newsandevents/?id=25466; http://www.ris.org.in/round-table-governance-regenerative-medicine-and-patients'-needs-india), (in India, for example, with members from the ICMR, Stempeutics, Neurogen, Indian Institute of Science, a patient activist, and the head of the Muscular Dystrophy Foundation of India), upon which basis we created a consensus policy-briefings (http://www.centreforbionetworking.org/wp-content/uploads/2014/12/Policy-Briefing-India.pdf). We used similar methods in Beijing, China and in Seoul, South Korea. 

2. UCB banking and policy advising
The banking of umbilical cord blood (UCB) has surged globally, especially in Asia. Many discussions have taken place on the pros and cons of private and public umbilical cord blood banking, where private UCB banking has been rejected in many European countries, as the stored samples would be used inefficiently. On the basis of research into the donation, storage and exchange of umbilical cord blood in India, Japan, Taiwan and China (Chang &amp;amp; Sleeboom-Faulkner, special issue in New Genetics and Society, 2016), we found that public UCB banking is simply too expensive in some countries, where new forms of umbilical cord banking have come about (Chang 2015: http://www.palgrave-journals.com/biosoc/journal/vaop/ncurrent/abs/biosoc201529a.html; http://www.ppssc.com.tw/file/Oral%20Session.pdf). Team member Dr Hung-Chieh Chang describes this as 'hybrid banking' in Nature (http://www.nature.com/nbt/journal/v32/n4/full/nbt.2866.html), insights that have caught the attention of the Shanghai Cord Blood Bank, where Chang has been invited to discuss her work and conduct further research (which is in the stage of being written up). The UCB research of team member, Dr Suli Sui, Peking Union Medical College has been conducive to new ethics regulation in China, about which she has been interviewed by the press and TV in China (http://www.aiweibang.com/yuedu/5126303.html). Furthermore, Rosemann, Nattaka Chaisinthop and Sleeboom-Faulkner served as consultants on the ethics of cell therapies for various projects (http://www.centreforbionetworking.org/wp-content/uploads/2013/12/What-is-Fresh-Cell-Therapy.pdf; http://fyy.sdfyy.cn/Main/NewsView_B255_A8345.html). 
 
3. International regulation and stem cell research
The challenges of regulating 'stem cell tourism' in the UK and Asia were discussed at a public event with private sector representatives, scientists, lawyers and researchers in 2013 (http://www.centreforbionetworking.org/news-and-events/regulating-stem-cell-tourism-in-the-uk-and-asia-how-do-we-move-forward-together/). Research on how 'international' regulation (e.g., that of the ISSCR and NIH) impacts and plays out in different countries led to the insight that between bona fide research and 'snake oil research' there exists a massive 'grey area', about which there is very little agreement even among reputed scientists (Sleeboom-Faulkner et al, 2016: http://www.journals.elsevier.com/social-science-and-medicine/open-access-articles/; Sleeboom-Faulkner, 2016). Our three special issues on cord blood banking, regulatory values, global stem cell ethics, and biomedical platforms and bionetworking (Chang &amp;amp; Sleeboom-Faulkner 2016; Heitmeyer &amp;amp; Chekar 2017; Rosemann 2017) underpinned an international debate in Sussex on 'The Grey Area Between Bona Fide and Rogue Stem Cell Science' with 6 internationally well-known scientists (Geeta Shroff, Alok Sharma, Hongyun Huang, Paolo Bianco, Kamthorn Pruksananonda and Willem Fibbe) (http://www.sussex.ac.uk/staff/newsandevents/?id=27655; http://www.eurostemcell.org/story/centre-bionetworking-organises-international-conference-'global-life-science-and-bionetworking, as well as website debate: http://tinyurl.com/bionetworking). While publishing steps towards more practicable regulation on the basis of 'annotated consensus', Sleeboom-Faulkner has participated in deliberation on 'Towards consensus on marketing and regulation of emerging and unproven stem cell treatments' in December 2015 (Brocher Foundation) establishing a declaration on 'Marketing and Delivery of Unproven Stem Cell-Based Interventions: A Call to Action'). 

4. Patient organisations and knowledge activism
Our research with patient organisations in Asia, especially patient organisations for muscular dystrophy and spinal cord injury, has led us to the realisation that there is much prejudice among patient organisations, notably the international groups based in wealthy countries, about how patient organisations need to support patients, carers and their families, and how they go about their activities in relation to the search for therapy/cures, collaboration with medical professionals and scientists, and 'knowledge activism' (Sleeboom-Faulkner; Heitmeyer, under review). This has led to an international workshop on 'Patient Organisation Activism Around the World' (18-19 May 2015, report: http://www.centreforbionetworking.org/wp-content/uploads/2015/04/Report-International-Workshop-in-Brighton.pdf), after which patient organisations started using the outcomes of this workshop in their activities. We are in the process of writing a publication together, and expect to have impact on patients' attitudes towards stem cell therapy and stem cell tourism.</gtr:description><gtr:firstYearOfImpact>2013</gtr:firstYearOfImpact><gtr:id>E48BBB85-699E-48F5-8CC9-35412237857A</gtr:id><gtr:impactTypes><gtr:impactType>Cultural,Societal,Policy &amp; public services</gtr:impactType></gtr:impactTypes><gtr:outcomeId>56dee0763282f1.09955678</gtr:outcomeId><gtr:sector>Education,Healthcare,Government, Democracy and Justice</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>'Bionetworking in Asia' has three main objectives: First, the development of a theoretical framework for 'bionetworking' to capture the managerial, cognitive, infrastructural, experimental and exchange activities and strategies that make (up) knowledge about life, health, and medicine. Bionetworking involves the tracing, mapping, and explaining of decisions that have led to particular kinds of collaborative research, investment, IPR, clinical trials, experimentation, standards, values and effects of the production and products of biotechnology, including both elements of co-operation and competition (Sleeboom-Faulkner 2014); Second, to explore bionetworking in transnational and national collaborations in regenerative medicine and biobanking using fieldwork methods of participant observation/backward mapping, archival research and interviews; and, Third, to gain insights into patient needs and the extent to which advanced biomedicine can cater to them through workshops and roundtables, having developed the method of Criteria and Option Generation Deliberative Workshops (COG-DW) and public debate (building on Andy Stirling's Multi-Criteria Mapping).

Our main findings concern: 
1. Scientific and ethical stem cell applications: Our bionetworking approach used in field research in India, Malaysia Thailand, South Korea, China and Japan corrects common views that stem cell therapies are either 'scientific and ethical' or 'rogue and unethical': between these two extremes there is a very large grey area of stem cell therapy provision, where distinctions between scientific from non-scientific, and ethical from unethical are widely disputed (Sleeboom-Faulkner 2014, 2016; Ely and Sleeboom-Faulkner; Sleeboom-Faulkner UR)
2. Regulatory issues: A common notion has it that 'the East' and 'less developed countries' are homes to inferior medical services. Our research, mapping transnational collaborations, however, shows that the traffic of 'stem cell tourism' goes both ways: providers of 'unproven therapies' in Germany attract medical tourism from Thailand (Chaisinthop and Rosemann; Rosemann, UR); and therapy centres in Japan attracted patients from South Korea (Sleeboom-Faulkner, UR). Furthermore, the fact that some countries develop 'therapy products' does not reflect permissive cultures, but different modes of regulatory regimes. Frequently, it is the regulatory set up in a country that shapes these patient flows and research (Sleeboom-Faulkner 2013, 2016; Sleeboom and Patra; Huang; Huang and Sleeboom-Faulkner; Sleeboom; Rosemann 2013, under review; Sleeboom-Faulkner and Heitmeyer; Chaisinthop; Kato and Sleeboom-Faulkner; Sleeboom-Faulkner). 
3. Stem cell banking: Umbilical cord blood banking in private banks has often been regarded as fraudulent. Our research nuances this view by mapping and analyzing the actual infrastructures, strategic networks and use of public and private umbilical cord banks (Chang and Sleeboom-Faulkner; Sleeboom-Faulkner 2016; Sui 2015; Sleeboom-Faulkner and Heitmeyer; Patra 2016; Patra Sleeboom-Faulkner; Sleeboom-Faulkner).
4. Patient needs: Roundtable Debates in South Korea (May 2014), Bangalore (September 2013) and Beijing (March 2014) and New Delhi (July 2014) and COG-DW concerning patient needs and the extent to which stem cell research caters to these needs shows great variety in the kinds of expectations patients have from regenerative medicine, and that an 'ethics of return' for investment in stem cell technology in the form of therapy is becoming an important public issue (Sleeboom-Faulkner, Heitmeyer and Patra). (Seoul Roundtable: http://www.sussex.ac.uk/newsandevents/?id=25081; Beijing Roundtable: http://www.sussex.ac.uk/anthropology/newsandevents/?id=24184)</gtr:description><gtr:exploitationPathways>1) Our research shows that effective harmonisation of research regulations can only work by taking into account the position of 'rogue' stem cell researchers that are inadequately equipped, but 'hamper' scientific progress. The PI will lead a position paper with stakeholders, to be used in the revision of current research guidelines (December 2016); 
2) The PI will organize a joint article with patient groups and the role of science in catering these from a global perspective. Meetings have already resulted in a report (see: http://www.centreforbionetworking.org/wp-content/uploads/2015/04/Report-International-Workshop-in-Brighton.pdf ) and policy-briefings (see http://www.centreforbionetworking.org/educational-resources/briefings/ ).
3) The research led to new insights into the interdisciplinarity of regenerative medicine, linking stem cell science with the booming field of genomics research. The notion of bionetworking and the insights outlined above form the basis of new research projects: (a) bionetworking practices and the framework of choice in new reproductive technologies (Sleeboom-Faulkner); (b) Bionetworking and needs of children with muscular dystrophy (Chang); (c) The views of patients with different conditions on the role of advanced medicine (Kato); (d) Other researchers can adopt the bionetworking approach (e.g, the Portuguese Research Council has funded &amp;quot;bionetworking and citizenship in gamete donation&amp;quot;(Susana da Silva).</gtr:exploitationPathways><gtr:id>1166AA7C-2601-468F-9EB6-8E7E86C4DE10</gtr:id><gtr:outcomeId>5464815d759e43.18021279</gtr:outcomeId><gtr:sectors><gtr:sector>Healthcare,Government, Democracy and Justice,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://www.centreforbionetworking.org</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>C87C790E-56C4-490C-88C3-FEF20991E5BD</gtr:id><gtr:title>The formalization of social-science research ethics</gtr:title><gtr:parentPublicationTitle>HAU: Journal of Ethnographic Theory</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3364d02a35d58c42051fae4614d0425e"><gtr:id>3364d02a35d58c42051fae4614d0425e</gtr:id><gtr:otherNames>Sleeboom-Faulkner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5aa280f4e53107.34155218</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5080DE0-E262-4263-88D9-D35574E20CBB</gtr:id><gtr:title>Experimental Ethics: Emergent themes and issues in life sciences research in Asia</gtr:title><gtr:parentPublicationTitle>BioSocieties</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3364d02a35d58c42051fae4614d0425e"><gtr:id>3364d02a35d58c42051fae4614d0425e</gtr:id><gtr:otherNames>Sleeboom-Faulkner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>doi_53cf97f975c50ffe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4035052-B150-4825-B964-8748803CD35E</gtr:id><gtr:title>&amp;quot;(East) Asia&amp;quot; as a Platform for Debate: Grouping and Bioethics.</gtr:title><gtr:parentPublicationTitle>Kennedy Institute of Ethics journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3364d02a35d58c42051fae4614d0425e"><gtr:id>3364d02a35d58c42051fae4614d0425e</gtr:id><gtr:otherNames>Sleeboom-Faulkner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1054-6863</gtr:issn><gtr:outcomeId>58a5da90854c00.96941634</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0354EE2E-820D-4E43-B52B-77215E99FF0E</gtr:id><gtr:title>Ova collection in Japan &amp;acirc;?? making visible women's experience in male spaces</gtr:title><gtr:parentPublicationTitle>Gender, Place &amp; Culture</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64cb416bc3a1e987e07aa877c0efc289"><gtr:id>64cb416bc3a1e987e07aa877c0efc289</gtr:id><gtr:otherNames>Kato M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>56c1bba94a9155.72170480</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85835405-9F5D-4DFA-B071-9C08806F7304</gtr:id><gtr:title>Global Morality and Life Science Practices in Asia: Assemblages of Life</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93eb8c4e41b50cacb2076eac5a3379d0"><gtr:id>93eb8c4e41b50cacb2076eac5a3379d0</gtr:id><gtr:otherNames>Sleeboom-Faulkner Margaret</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:isbn>9780230274839</gtr:isbn><gtr:outcomeId>55c22bc1eccaa4.45082221</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40A9069A-4612-46D5-9DE5-E81041CA20A1</gtr:id><gtr:title>The third way of umbilical cord blood banking.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fc5836b00aef4b5ce2848b03ac4ca1a"><gtr:id>0fc5836b00aef4b5ce2848b03ac4ca1a</gtr:id><gtr:otherNames>Chang HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>5453a0971e3f96.15615310</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7FA4113-17A4-454A-A1E5-091205B7EE35</gtr:id><gtr:title>The Understanding on the Governance of Stem Cell in China</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a64b691f76a5cf53f590311add415cd2"><gtr:id>a64b691f76a5cf53f590311add415cd2</gtr:id><gtr:otherNames>Sui, S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>55c2264a74f9a2.54081541</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20BB4A02-891E-41C1-A4D6-1B9DCC49FD22</gtr:id><gtr:title>Genomics and cure: understanding narratives of patients with Duchenne muscular dystrophy in Japan.</gtr:title><gtr:parentPublicationTitle>Anthropology &amp; medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64cb416bc3a1e987e07aa877c0efc289"><gtr:id>64cb416bc3a1e987e07aa877c0efc289</gtr:id><gtr:otherNames>Kato M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1364-8470</gtr:issn><gtr:outcomeId>5aa968cb0bfd74.59973793</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7098D752-AD29-4B81-AE5D-36F889ED2038</gtr:id><gtr:title>Biogovernance Beyond the State: The Shaping of Stem Cell Therapy by Patient Organizations in India.</gtr:title><gtr:parentPublicationTitle>Medical anthropology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/704e988a19cd2c29331c93a5248abf63"><gtr:id>704e988a19cd2c29331c93a5248abf63</gtr:id><gtr:otherNames>Heitmeyer C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0145-9740</gtr:issn><gtr:outcomeId>587391ae219427.25202015</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CEFF8D12-A3D8-4E17-B3C4-E16139E0CD20</gtr:id><gtr:title>The cord blood bank and its related issues in China</gtr:title><gtr:parentPublicationTitle>Chinese Journal of Family Planning</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a64b691f76a5cf53f590311add415cd2"><gtr:id>a64b691f76a5cf53f590311add415cd2</gtr:id><gtr:otherNames>Sui, S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>55c22ab30ba833.95973317</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F67E75F7-A660-4B73-AA4D-B46F8AA9C89C</gtr:id><gtr:title>Global regulatory developments for clinical stem cell research: diversification and challenges to collaborations.</gtr:title><gtr:parentPublicationTitle>Regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24020ce6bf551895592e1ff32fa9bfb5"><gtr:id>24020ce6bf551895592e1ff32fa9bfb5</gtr:id><gtr:otherNames>Rosemann A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1746-0751</gtr:issn><gtr:outcomeId>585d63982943a7.65101390</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3447952B-57AF-49BA-910C-E9B713111578</gtr:id><gtr:title>Multi-country stem cell trials: The need for an international support structure.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24020ce6bf551895592e1ff32fa9bfb5"><gtr:id>24020ce6bf551895592e1ff32fa9bfb5</gtr:id><gtr:otherNames>Rosemann A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>5649f0154a4296.91698857</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B9C285F-FF1C-4F94-B5A4-0C455ED22CDB</gtr:id><gtr:title>The multiple roles of cord blood banks in Taiwan: competition and collaboration</gtr:title><gtr:parentPublicationTitle>New Genetics and Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f45c653e46f15babfc7fef9a3c1f5a7"><gtr:id>5f45c653e46f15babfc7fef9a3c1f5a7</gtr:id><gtr:otherNames>Chang H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>585d54f9936f97.28259106</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ADA09CCC-1B33-4D8C-B1B8-FDCAB6221A8D</gtr:id><gtr:title>Discursive dialects of bioethics: Understanding the institutional embeddings of human stem cell experimentation in India</gtr:title><gtr:parentPublicationTitle>BioSocieties</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5666c3b10954d391e677ee4cff7d374"><gtr:id>e5666c3b10954d391e677ee4cff7d374</gtr:id><gtr:otherNames>Patra P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>545b92351da8b8.05530140</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C97EC92-5CEB-4945-8E72-95A4542D7D53</gtr:id><gtr:title>Governance of stem cell research: public participation and decision-making in China, Japan, South Korea and Taiwan.</gtr:title><gtr:parentPublicationTitle>Social studies of science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3364d02a35d58c42051fae4614d0425e"><gtr:id>3364d02a35d58c42051fae4614d0425e</gtr:id><gtr:otherNames>Sleeboom-Faulkner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0306-3127</gtr:issn><gtr:outcomeId>pm_53cc018c018f79715</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E45CEE70-2451-4ED6-B716-29F064F6871A</gtr:id><gtr:title>Direct-to-consumer genetic testing in China, in Vital Signs: Medical Anthropology In The 21st Century</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a64b691f76a5cf53f590311add415cd2"><gtr:id>a64b691f76a5cf53f590311add415cd2</gtr:id><gtr:otherNames>Sui, S</gtr:otherNames></gtr:author></gtr:authors><gtr:isbn>978-1-13-801563-0</gtr:isbn><gtr:outcomeId>564b036bcec238.86632539</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D99B6E39-ACD0-41ED-B94E-DCA7C24271D7</gtr:id><gtr:title>Stem Cells in Clinical Applications: Safety, Ethics and Regulations</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6d9340c1c1b432a28734af82018b858"><gtr:id>b6d9340c1c1b432a28734af82018b858</gtr:id><gtr:otherNames>Rosemann, A.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5877852977ed57.97852298</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A53563A-C009-43FE-AEE4-64451E558AB4</gtr:id><gtr:title>Translating 'Asian' Modes of Healing and Biomedicine.</gtr:title><gtr:parentPublicationTitle>Medical anthropology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3364d02a35d58c42051fae4614d0425e"><gtr:id>3364d02a35d58c42051fae4614d0425e</gtr:id><gtr:otherNames>Sleeboom-Faulkner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0145-9740</gtr:issn><gtr:outcomeId>564a05d8ddb5e1.89803902</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD407EE4-3DD1-4C00-B852-7AD79DF1644D</gtr:id><gtr:title>Governance of Stem Cell Research and Its Clinical Translation in China: An Example of Profit-Oriented Bionetworking</gtr:title><gtr:parentPublicationTitle>East Asian Science, Technology and Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88347ea68ed86439a7ac1315fdf25ceb"><gtr:id>88347ea68ed86439a7ac1315fdf25ceb</gtr:id><gtr:otherNames>Sui S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>5649fb0f859cd4.75249432</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93C7A232-A2A2-4163-9AB3-E3CC2E8FD12A</gtr:id><gtr:title>Stem Cells in Clinical Applications</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ab15164cdaf725cdd2db046d17df8ca"><gtr:id>2ab15164cdaf725cdd2db046d17df8ca</gtr:id><gtr:otherNames>Rosemann, A</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>568e8d60d78510.97178882</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7078C426-9678-481B-BCCC-646EFB3B38F0</gtr:id><gtr:title>Scientific Multipolarisation: Its Impact on International Clinical Research Collaborations and Theoretical Implications</gtr:title><gtr:parentPublicationTitle>Science, Technology and Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24020ce6bf551895592e1ff32fa9bfb5"><gtr:id>24020ce6bf551895592e1ff32fa9bfb5</gtr:id><gtr:otherNames>Rosemann A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>r_6948124376cb320c72</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6047BCC-BE62-4768-838A-ED5BCA5A799B</gtr:id><gtr:title>The private, the public and the hybrid in umbilical cord blood banking &amp;acirc;?? a global perspective</gtr:title><gtr:parentPublicationTitle>New Genetics and Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/346149c4bf35b86b6b61cb81d8d8f71a"><gtr:id>346149c4bf35b86b6b61cb81d8d8f71a</gtr:id><gtr:otherNames>Sleeboom-Faulkener M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>585d54ff48b2e2.05165893</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B9EDD49-ED5C-491B-AA42-8784C60606B4</gtr:id><gtr:title>Stem Cells in Clinical Applications: Safety, Ethics and Regulations</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6d9340c1c1b432a28734af82018b858"><gtr:id>b6d9340c1c1b432a28734af82018b858</gtr:id><gtr:otherNames>Rosemann, A.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>58778a7a341132.76476710</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>757FDB30-EAC7-40B1-9DC3-E098C69913D4</gtr:id><gtr:title>New regulation for clinical stem cell research in China: expected impact and challenges for implementation.</gtr:title><gtr:parentPublicationTitle>Regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24020ce6bf551895592e1ff32fa9bfb5"><gtr:id>24020ce6bf551895592e1ff32fa9bfb5</gtr:id><gtr:otherNames>Rosemann A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1746-0751</gtr:issn><gtr:outcomeId>564a0581acca01.24867136</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06EF042C-643B-45F0-8B86-C78453B402C6</gtr:id><gtr:title>Latent science collaboration: Strategies of bioethical capacity building in Mainland China's stem cell world</gtr:title><gtr:parentPublicationTitle>BioSocieties</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3364d02a35d58c42051fae4614d0425e"><gtr:id>3364d02a35d58c42051fae4614d0425e</gtr:id><gtr:otherNames>Sleeboom-Faulkner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>doi_53cf97f975d09283</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13342CC3-0AAB-446B-B749-8B13D94E067C</gtr:id><gtr:title>Giving a Gift to the Gift: Women's Experiences of Embryo Donation in Japan</gtr:title><gtr:parentPublicationTitle>Anthropological Forum</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64cb416bc3a1e987e07aa877c0efc289"><gtr:id>64cb416bc3a1e987e07aa877c0efc289</gtr:id><gtr:otherNames>Kato M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>545b9346751553.94633528</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC8D826F-6734-43C8-812E-6DE58CCF39A3</gtr:id><gtr:title>Why regenerative stem cell medicine progresses slower than expected.</gtr:title><gtr:parentPublicationTitle>Journal of cellular biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24020ce6bf551895592e1ff32fa9bfb5"><gtr:id>24020ce6bf551895592e1ff32fa9bfb5</gtr:id><gtr:otherNames>Rosemann A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0730-2312</gtr:issn><gtr:outcomeId>546e0f3d944fc0.91241036</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F613A1C-038A-48AD-8228-91D0DAD85F02</gtr:id><gtr:title>Competitive Adaptation: Biobanking and Bioethical Governance in China Medical City</gtr:title><gtr:parentPublicationTitle>East Asian Science, Technology and Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3364d02a35d58c42051fae4614d0425e"><gtr:id>3364d02a35d58c42051fae4614d0425e</gtr:id><gtr:otherNames>Sleeboom-Faulkner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>545b92d431c575.12920057</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>140A1528-4A92-4C44-8AA2-6C6A44D9D3E2</gtr:id><gtr:title>Localising the 'ethical' in stem cell science: Case studies from Asia, North America and Europe.</gtr:title><gtr:parentPublicationTitle>Developing world bioethics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e361b486906c4d6375153622704b8136"><gtr:id>e361b486906c4d6375153622704b8136</gtr:id><gtr:otherNames>Chekar CK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1471-8731</gtr:issn><gtr:outcomeId>5a2fcaf9a583e8.11261584</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4BEE48E-FBD9-447E-A407-4A66017D9AF5</gtr:id><gtr:title>Commercial Genetic Testing and its Governance in Chinese Society</gtr:title><gtr:parentPublicationTitle>Minerva</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88347ea68ed86439a7ac1315fdf25ceb"><gtr:id>88347ea68ed86439a7ac1315fdf25ceb</gtr:id><gtr:otherNames>Sui S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>5649b640a81140.16620846</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4F0E0B8-D103-4CE9-9A17-0CFD4E498CC2</gtr:id><gtr:title>The Matrix of Stem Cell Research Revisited</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ab15164cdaf725cdd2db046d17df8ca"><gtr:id>2ab15164cdaf725cdd2db046d17df8ca</gtr:id><gtr:otherNames>Rosemann, A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>58777cf85c61d7.01950906</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>392514CD-8F66-41CC-985B-303D1827BFE1</gtr:id><gtr:title>Special focus issue on regenerative medicine in society: interdisciplinary perspectives (part I) - Foreword.</gtr:title><gtr:parentPublicationTitle>Regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24020ce6bf551895592e1ff32fa9bfb5"><gtr:id>24020ce6bf551895592e1ff32fa9bfb5</gtr:id><gtr:otherNames>Rosemann A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1746-0751</gtr:issn><gtr:outcomeId>5a9595fb3faa30.25271930</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6CE64C13-6AE7-4EA4-BA0A-20B8C20C4234</gtr:id><gtr:title>&amp;acirc;??The good child&amp;acirc;??: Anthropological perspectives on morality and childhood</gtr:title><gtr:parentPublicationTitle>Journal of Moral Education</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/113b10756a97dfe5de9e2d98d45a2c7e"><gtr:id>113b10756a97dfe5de9e2d98d45a2c7e</gtr:id><gtr:otherNames>Fechter A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>55c22dff7275d0.39072173</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CFE453FF-93DA-43A1-8220-76E0ADA0F5CD</gtr:id><gtr:title>IS STEM CELL THERAPY A LIFESAVER? PATIENTS' EXPERIENCES OF AND VIEWS ON STEM CELL THERAPY IN CHINA2</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88347ea68ed86439a7ac1315fdf25ceb"><gtr:id>88347ea68ed86439a7ac1315fdf25ceb</gtr:id><gtr:otherNames>Sui S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>55a62faa794830.98885719</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46E695FC-7070-4110-8625-706946E1BD9A</gtr:id><gtr:title>Learning from and working with the diabetes patients for patient advocacy</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee81ca88ba433a56fb873f9d3d1ae425"><gtr:id>ee81ca88ba433a56fb873f9d3d1ae425</gtr:id><gtr:otherNames>Su Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>55a6369edec819.60342090</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83D25060-8B3C-4FAF-95B3-5EF1CE98726C</gtr:id><gtr:title>Stem Cell Research in Asia: Looking Beyond Regulatory Exteriors</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ab15164cdaf725cdd2db046d17df8ca"><gtr:id>2ab15164cdaf725cdd2db046d17df8ca</gtr:id><gtr:otherNames>Rosemann, A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:isbn>978-1-13-882931-2</gtr:isbn><gtr:outcomeId>545b3c0c759653.31394726</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E73353DD-9C7A-4DE6-A823-C50480F6E6D8</gtr:id><gtr:title>Special focus issue on regenerative medicine in society: interdisciplinary perspectives (part II) - Foreword.</gtr:title><gtr:parentPublicationTitle>Regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23d4ae6ab5ca03cc252c9b5a3bb53c30"><gtr:id>23d4ae6ab5ca03cc252c9b5a3bb53c30</gtr:id><gtr:otherNames>Barfoot J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1746-0751</gtr:issn><gtr:outcomeId>5a95964d609c45.69577185</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A32A73B2-0AB6-4981-A9CC-8F7202C96FBF</gtr:id><gtr:title>The pluralization of the international: Resistance and alter-standardization in regenerative stem cell medicine.</gtr:title><gtr:parentPublicationTitle>Social studies of science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24020ce6bf551895592e1ff32fa9bfb5"><gtr:id>24020ce6bf551895592e1ff32fa9bfb5</gtr:id><gtr:otherNames>Rosemann A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0306-3127</gtr:issn><gtr:outcomeId>5649fcda02c586.45654440</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1490E3BE-7C3C-4D12-9E9A-1322ABABB977</gtr:id><gtr:title>From global bioethics to ethical governance of biomedical research collaborations.</gtr:title><gtr:parentPublicationTitle>Social science &amp; medicine (1982)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de1a2a244cc1fb54d8781886dd16938f"><gtr:id>de1a2a244cc1fb54d8781886dd16938f</gtr:id><gtr:otherNames>Wahlberg A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0277-9536</gtr:issn><gtr:outcomeId>545b919308a186.42207634</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5CFC9E9C-2369-45E7-8435-5C15E538928A</gtr:id><gtr:title>Medical innovation and national experimental pluralism: Insights from clinical stem cell research and applications in China</gtr:title><gtr:parentPublicationTitle>BioSocieties</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24020ce6bf551895592e1ff32fa9bfb5"><gtr:id>24020ce6bf551895592e1ff32fa9bfb5</gtr:id><gtr:otherNames>Rosemann A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>55d5efbd7012b8.94329388</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF0D9836-DCA5-4CC3-9A1A-E25AB21B96B4</gtr:id><gtr:title>The Twenty-First-Century Gift and the Co-circulation of Things</gtr:title><gtr:parentPublicationTitle>Anthropological Forum</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3364d02a35d58c42051fae4614d0425e"><gtr:id>3364d02a35d58c42051fae4614d0425e</gtr:id><gtr:otherNames>Sleeboom-Faulkner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>564a0641d09289.33962653</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CCE86B62-850E-4823-B28A-C63B3FFB6545</gtr:id><gtr:title>Regulating &amp;acirc;??Respect&amp;acirc;?? for the Embryo: Social Mindscapes and Human Embryonic Stem Cell Research in Japan</gtr:title><gtr:parentPublicationTitle>Science, Technology and Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3364d02a35d58c42051fae4614d0425e"><gtr:id>3364d02a35d58c42051fae4614d0425e</gtr:id><gtr:otherNames>Sleeboom-Faulkner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>545b99f49c6b18.91120362</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F558BBB-6A74-49AA-AAC7-9EAF00E23338</gtr:id><gtr:title>The large grey area between &amp;acirc;??bona fide&amp;acirc;?? and &amp;acirc;??rogue&amp;acirc;?? stem cell interventions &amp;acirc;?? Ethical acceptability and the need to include local variability</gtr:title><gtr:parentPublicationTitle>Technological Forecasting and Social Change</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3364d02a35d58c42051fae4614d0425e"><gtr:id>3364d02a35d58c42051fae4614d0425e</gtr:id><gtr:otherNames>Sleeboom-Faulkner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>576571999bd680.97621280</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1A5CB49-B3FB-40F9-B52C-2382C137617D</gtr:id><gtr:title>Bioethical Governance in South Korea: Tensions between Bottom-Up Movement and Professionalization and Scientific Citizenship</gtr:title><gtr:parentPublicationTitle>East Asian Science, Technology and Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51f72f0857a0ef15c335da5bc7273bae"><gtr:id>51f72f0857a0ef15c335da5bc7273bae</gtr:id><gtr:otherNames>Hwang S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>545b93b485c262.11134370</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>862AA69A-6553-417C-A246-74874CFEA803</gtr:id><gtr:title>Innovia Newsletter</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a64b691f76a5cf53f590311add415cd2"><gtr:id>a64b691f76a5cf53f590311add415cd2</gtr:id><gtr:otherNames>Sui, S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>55c22732a210a3.53889825</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C450C0F-BCA2-44F8-A9BC-3F799583B0E3</gtr:id><gtr:title>Stem Cells in Clinical Applications: Safety, Ethics and Regulations</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35e680d002dd28e52bc4578c46d72218"><gtr:id>35e680d002dd28e52bc4578c46d72218</gtr:id><gtr:otherNames>Rosemann, A.,</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>587783f51af0d0.07474688</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94E7F66D-5C4D-46C7-B30A-5B74FFAE3B87</gtr:id><gtr:title>Looking beyond the regulatory exteriors of stem cell research in Asia &amp;acirc;?? discussion</gtr:title><gtr:parentPublicationTitle>New Genetics and Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3364d02a35d58c42051fae4614d0425e"><gtr:id>3364d02a35d58c42051fae4614d0425e</gtr:id><gtr:otherNames>Sleeboom-Faulkner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>55c22c569072d3.43413727</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>526011B4-1B50-4455-8FE9-10F0B1B82903</gtr:id><gtr:title>Regulatory capacity building and the governance of clinical stem cell research in China</gtr:title><gtr:parentPublicationTitle>Science and Public Policy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3364d02a35d58c42051fae4614d0425e"><gtr:id>3364d02a35d58c42051fae4614d0425e</gtr:id><gtr:otherNames>Sleeboom-Faulkner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a995c79a7c1b2.13418362</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94E1D89A-0720-4BD8-8354-E4FA9899A572</gtr:id><gtr:title>Ethical Reflection on Epidemiological Research in China</gtr:title><gtr:parentPublicationTitle>Chinese Medical Ethics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4930a4a8ab82ee0ee3e11675d1b983bf"><gtr:id>4930a4a8ab82ee0ee3e11675d1b983bf</gtr:id><gtr:otherNames>Wang, L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>55c88c97071c25.12556322</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B803AF7E-05D5-49FE-9738-4B66AACAE00D</gtr:id><gtr:title>Following the banking cycle of umbilical cord blood in India: the disparity between pre-banking persuasion and post-banking utilization</gtr:title><gtr:parentPublicationTitle>New Genetics and Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5666c3b10954d391e677ee4cff7d374"><gtr:id>e5666c3b10954d391e677ee4cff7d374</gtr:id><gtr:otherNames>Patra P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>585d54fc71d847.01694114</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3E91650-A15F-4B97-8DAB-C4A81C28B3A2</gtr:id><gtr:title>The normalisation of body gifting in Taiwan</gtr:title><gtr:parentPublicationTitle>BioSocieties</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f45c653e46f15babfc7fef9a3c1f5a7"><gtr:id>5f45c653e46f15babfc7fef9a3c1f5a7</gtr:id><gtr:otherNames>Chang H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>55d714d89af461.04607909</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D28C5AE-CE1D-4EC1-A883-68B3B4B28C8E</gtr:id><gtr:title>Modalities of value, exchange, solidarity: the social life of stem cells in China</gtr:title><gtr:parentPublicationTitle>New Genetics and Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24020ce6bf551895592e1ff32fa9bfb5"><gtr:id>24020ce6bf551895592e1ff32fa9bfb5</gtr:id><gtr:otherNames>Rosemann A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>55c0b5aaef1bd3.99431663</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72AFC157-38CC-416D-893B-440575A2EA3B</gtr:id><gtr:title>The role of policies and networks in development of cord blood usage in China.</gtr:title><gtr:parentPublicationTitle>Regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fc5836b00aef4b5ce2848b03ac4ca1a"><gtr:id>0fc5836b00aef4b5ce2848b03ac4ca1a</gtr:id><gtr:otherNames>Chang HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1746-0751</gtr:issn><gtr:outcomeId>5aa27ce155d210.67273532</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7776B427-B219-4E5F-AE31-D01FABE7432E</gtr:id><gtr:title>Stem cell treatments for neurodegenerative diseases: challenges from a science, business and healthcare perspective.</gtr:title><gtr:parentPublicationTitle>Neurodegenerative disease management</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24020ce6bf551895592e1ff32fa9bfb5"><gtr:id>24020ce6bf551895592e1ff32fa9bfb5</gtr:id><gtr:otherNames>Rosemann A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1758-2024</gtr:issn><gtr:outcomeId>55c0b4bb3d4e54.86206732</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2208A03-E779-407A-A3A4-57A48F8B3C0F</gtr:id><gtr:title>Standardization as situation-specific achievement: regulatory diversity and the production of value in intercontinental collaborations in stem cell medicine.</gtr:title><gtr:parentPublicationTitle>Social science &amp; medicine (1982)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24020ce6bf551895592e1ff32fa9bfb5"><gtr:id>24020ce6bf551895592e1ff32fa9bfb5</gtr:id><gtr:otherNames>Rosemann A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0277-9536</gtr:issn><gtr:outcomeId>546e0f689e1130.79012098</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>421246D2-F526-4118-ADC9-F0A4AA2555A1</gtr:id><gtr:title>Comparing national home-keeping and the regulation of translational stem cell applications: An international perspective.</gtr:title><gtr:parentPublicationTitle>Social science &amp; medicine (1982)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3364d02a35d58c42051fae4614d0425e"><gtr:id>3364d02a35d58c42051fae4614d0425e</gtr:id><gtr:otherNames>Sleeboom-Faulkner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0277-9536</gtr:issn><gtr:outcomeId>56b1ee237a9cb6.73697163</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C297C1F-0ABE-44C3-B067-01F245B89074</gtr:id><gtr:title>Human Germ Line Gene Editing: Why Comparative, Cross-National Studies of Public Viewpoints are Important?</gtr:title><gtr:parentPublicationTitle>Anthropology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24020ce6bf551895592e1ff32fa9bfb5"><gtr:id>24020ce6bf551895592e1ff32fa9bfb5</gtr:id><gtr:otherNames>Rosemann A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a958cb18ab982.78238168</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">ES/I018107/1</gtr:identifier><gtr:identifier type="RES">RES-062-23-2990</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>EBACD6D4-D1E5-4970-8BEC-7F4568EB26BA</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Development studies</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>020361E1-B8CA-49FD-9149-27D31D21C7A3</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Social Anthropology</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>F0322ED6-113F-4530-BA5E-562216587E68</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Sociology</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>32A0976A-B577-4829-A940-9AB6B148F977</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Area &amp; Development Studies</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>3FB490ED-1150-4B72-BB38-E3A211952C34</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Science &amp; Technology Studies</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>020361E1-B8CA-49FD-9149-27D31D21C7A3</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Social Anthropology</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>